Acquisition by Gulyani Meeta of 30500 shares of Seer at 2.18 subject to Rule 16b-3
| SEER Stock | USD 2.13 0.01 0.47% |
Slightly above 52% of Seer's investor base is interested to short. The analysis of overall sentiment of trading Seer Inc stock suggests that many investors are impartial at this time. Seer's investing sentiment overview a quick insight into current market opportunities from investing in Seer Inc. Many technical investors use Seer Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Filed transaction by Seer Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Seer Fundamental Analysis
We analyze Seer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Seer is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Seer Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Seer stock to make a market-neutral strategy. Peer analysis of Seer could also be used in its relative valuation, which is a method of valuing Seer by comparing valuation metrics with similar companies.
Peers
Seer Related Equities
| STTK | Shattuck Labs | 33.78 | ||||
| MOLN | Molecular Partners | 7.95 | ||||
| HCWB | HCW Biologics | 6.90 | ||||
| FHTX | Foghorn Therapeutics | 3.01 | ||||
| MLYS | Mineralys Therapeutics, | 2.92 | ||||
| ORIC | Oric Pharmaceuticals | 2.57 | ||||
| NRIX | Nurix Therapeutics | 2.17 | ||||
| GLUE | Monte Rosa | 1.88 | ||||
| CGEM | Cullinan Oncology | 1.76 | ||||
| ANTX | AN2 Therapeutics | 0.95 | ||||
| SANA | Sana Biotechnology | 0.71 | ||||
| LYEL | Lyell Immunopharma | 0.53 | ||||
| GBIO | Generation Bio | 0.44 | ||||
| PEPG | PepGen | 0.75 | ||||
| CCCC | C4 Therapeutics | 0.94 | ||||
| PHVS | Pharvaris | 1.13 | ||||
| QSI | QuantumSi | 1.37 | ||||
| KYMR | Kymera Therapeutics | 1.58 | ||||
| NKTX | Nkarta | 2.30 | ||||
| ANEB | Anebulo Pharmaceuticals | 5.26 | ||||
| MNOV | MediciNova | 5.59 |
Additional Tools for Seer Stock Analysis
When running Seer's price analysis, check to measure Seer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seer is operating at the current time. Most of Seer's value examination focuses on studying past and present price action to predict the probability of Seer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seer's price. Additionally, you may evaluate how the addition of Seer to your portfolios can decrease your overall portfolio volatility.